In the next five years, the Samsung Electronics group intends to invest 450 trillion won (equivalent to 360 billion dollars) to accelerate its growth in the sectors of biopharmaceuticals and biotechnology applied to pharmaceuticals, semiconductors and other state-of-the-art technologies such as artificial intelligence. 80% of the resources, the South Korean giant reported in a statement, will be dedicated to research and development.
The multinational electronics company based in Suwon, South Korea, has announced that investments planned until 2026 are expected to ensure long-term growth in consumer electronics and home appliances, while allowing aggressive investments in sectors considered strategic for the future, such as the biopharmaceutical sector, in order to achieve positive results like those already achieved in the chip sector.
Samsung Electronics, the largest chip maker in the world, did not provide an exact breakdown of the planned investment, although it did specify that 80% of the investments will be made in South Korea, and that the announced figure overlaps with a previous 240 trillion won investment in the pipeline in August 2021. Overall, the announced financial plan represents a 30% increase in the company’s investments in the five-year period leading up to 2021, and is expected to lead to the creation of more than 80,000 jobs by 2026.
Samsung Electronics is building an advanced US $ 17 billion chip plant in Texas – a major achievement for the Biden administration, which considers the security of the semiconductor supply chain a priority to ensure by increasing its production capacity on the ground. American. Last week, the US president visited Samsung’s most advanced chip manufacturing facility on his first trip to Asia, highlighting joint efforts to safeguard the security of the semiconductor supply chain.